Guangdong Transtek Medical Electronics Co Ltd (300562) — Working Capital to Net Assets Ratio
Guangdong Transtek Medical Electronics Co Ltd (300562) has a Working Capital to Net Assets ratio of 56.9% as of September 2025. Working capital of CN¥564.54 Million (current assets of CN¥975.11 Million minus current liabilities of CN¥410.57 Million) is measured against net assets of CN¥992.41 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See 300562 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Guangdong Transtek Medical Electronics Co Ltd Working Capital to Net Assets (2011–2024)
This chart shows how Guangdong Transtek Medical Electronics Co Ltd's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 56.9%, reflecting working capital of CN¥564.54 Million against net assets of CN¥992.41 Million CNY. For the complete balance sheet picture, see 300562 total assets.
Annual Working Capital to Net Assets for Guangdong Transtek Medical Electronics Co Ltd (2011–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Guangdong Transtek Medical Electronics Co Ltd from 2011 to 2024, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check 300562 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 54.2% | CN¥529.64 Million | CN¥976.51 Million | CN¥1.05 Billion | CN¥516.91 Million | ▲ +4.5 pp |
| 2023 | 49.8% | CN¥509.88 Million | CN¥1.02 Billion | CN¥999.40 Million | CN¥489.52 Million | ▲ +1.3 pp |
| 2022 | 48.4% | CN¥483.81 Million | CN¥998.78 Million | CN¥985.13 Million | CN¥501.32 Million | ▲ +2.7 pp |
| 2021 | 45.8% | CN¥479.58 Million | CN¥1.05 Billion | CN¥1.19 Billion | CN¥711.35 Million | ▲ +13.1 pp |
| 2020 | 32.7% | CN¥213.95 Million | CN¥655.01 Million | CN¥927.74 Million | CN¥713.78 Million | ▼ -7.2 pp |
| 2019 | 39.9% | CN¥226.43 Million | CN¥568.05 Million | CN¥636.98 Million | CN¥410.55 Million | ▼ -6.5 pp |
| 2018 | 46.4% | CN¥246.65 Million | CN¥531.97 Million | CN¥592.41 Million | CN¥345.76 Million | ▼ -0.4 pp |
| 2017 | 46.7% | CN¥240.39 Million | CN¥514.28 Million | CN¥480.87 Million | CN¥240.48 Million | ▼ -23.9 pp |
| 2016 | 70.6% | CN¥357.39 Million | CN¥506.16 Million | CN¥510.04 Million | CN¥152.66 Million | ▲ +17.5 pp |
| 2015 | 53.2% | CN¥119.40 Million | CN¥224.63 Million | CN¥236.50 Million | CN¥117.09 Million | ▼ -4.2 pp |
| 2014 | 57.4% | CN¥108.29 Million | CN¥188.74 Million | CN¥211.00 Million | CN¥102.71 Million | ▲ +10.4 pp |
| 2013 | 47.0% | CN¥57.47 Million | CN¥122.26 Million | CN¥153.98 Million | CN¥96.51 Million | ▼ -17.9 pp |
| 2012 | 64.9% | CN¥59.45 Million | CN¥91.56 Million | CN¥127.50 Million | CN¥68.05 Million | ▲ +16.4 pp |
| 2011 | 48.6% | CN¥30.55 Million | CN¥62.90 Million | CN¥83.91 Million | CN¥53.36 Million | — |